BFM
MGRX icon

Boothbay Fund Management’s Mangoceuticals MGRX Stock Holding History

Boothbay Fund Management’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Hold
38,441
– – ﹤0.01% 2172
2026
Q1 		$13.8K Hold
38,441
– – ﹤0.01% 1984
2025
Q4 		$28.4K Buy
+38,441
New +$62.3K ﹤0.01% 1864

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Boothbay Fund Management's MGRX Position: Q2 2026 in Review

Boothbay Fund Management held its Mangoceuticals (MGRX) position steady in Q2 2026 at 38,441 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Boothbay Fund Management first reported a position in MGRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $28.4K in Q4 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • Boothbay Fund Management held 38,441 shares of Mangoceuticals worth $14.6K as of Q2 2026.
  • Boothbay Fund Management left its Mangoceuticals share count unchanged in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #2172 holding.
  • Boothbay Fund Management first reported a position in Mangoceuticals in Q4 2025 and has held it in 3 quarters since.
  • Boothbay Fund Management's Mangoceuticals position peaked at $28.4K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.